Please use this identifier to cite or link to this item: https://doi.org/10.1002/mbo3.193
DC FieldValue
dc.titleLipidomics and genomics of Mycobacterium tuberculosis reveal lineage-specific trends in mycolic acid biosynthesis
dc.contributor.authorPortevin D.
dc.contributor.authorSukumar S.
dc.contributor.authorCoscolla M.
dc.contributor.authorShui G.
dc.contributor.authorLi B.
dc.contributor.authorGuan X.L.
dc.contributor.authorBendt A.K.
dc.contributor.authorYoung D.
dc.contributor.authorGagneux S.
dc.contributor.authorWenk M.R.
dc.date.accessioned2020-09-08T03:20:38Z
dc.date.available2020-09-08T03:20:38Z
dc.date.issued2014
dc.identifier.citationPortevin D., Sukumar S., Coscolla M., Shui G., Li B., Guan X.L., Bendt A.K., Young D., Gagneux S., Wenk M.R. (2014). Lipidomics and genomics of Mycobacterium tuberculosis reveal lineage-specific trends in mycolic acid biosynthesis. MicrobiologyOpen 3 (6) : 823-835. ScholarBank@NUS Repository. https://doi.org/10.1002/mbo3.193
dc.identifier.issn2045-8827
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/174583
dc.description.abstractMycolic acids (MAs) are α-alkyl, β-hydroxy long-chain fatty acids found in abundance in the cell envelope of the Mycobacterium tuberculosis complex (MTBC). MAs form an efficient permeability barrier, modulate host innate immune responses, and are the targets of several anti-tuberculosis drugs. Using mass spectrometry, we measured the relative abundance of 80 MA species across 36 clinical isolates of MTBC covering four major phylogenetic lineages. We found significant variations in the MA patterns between different MTBC strains and lineages. MA patterns of "ancient" lineages contrasted those from "modern" lineages, with a lower representation of alpha-mycolates among Lineage 6 strains and an inversion of the methoxy: keto-mycolates ratio in Lineage 1 strains. By interrogating the whole genome sequences of these MTBC strains, we identified relevant single-nucleotide polymorphisms that may sustain the lineage-specific MA patterns. Our results show that the strain genetic background influences MA metabolism and suggests that strain diversity should be considered in the development of new anti-tuberculosis drugs that target MA synthesis. © 2014 The Authors. MicrobiologyOpen published by John Wiley & Sons Ltd..
dc.sourceUnpaywall 20200831
dc.subjectMycobacterium tuberculosis
dc.subjectmycolic acid
dc.subjectbacterial genome
dc.subjectchemistry
dc.subjectclassification
dc.subjectgenetics
dc.subjectgenomics
dc.subjecthuman
dc.subjectmass spectrometry
dc.subjectmetabolism
dc.subjectmicrobiology
dc.subjectMycobacterium tuberculosis
dc.subjectphylogeny
dc.subjectspecies difference
dc.subjecttuberculosis
dc.subjectGenome, Bacterial
dc.subjectGenomics
dc.subjectHumans
dc.subjectMass Spectrometry
dc.subjectMycobacterium tuberculosis
dc.subjectMycolic Acids
dc.subjectPhylogeny
dc.subjectSpecies Specificity
dc.subjectTuberculosis
dc.typeArticle
dc.contributor.departmentBIOCHEMISTRY
dc.contributor.departmentDEPARTMENT OF COMPUTER SCIENCE
dc.contributor.departmentLIFE SCIENCES INSTITUTE
dc.description.doi10.1002/mbo3.193
dc.description.sourcetitleMicrobiologyOpen
dc.description.volume3
dc.description.issue6
dc.description.page823-835
dc.published.statePublished
Appears in Collections:Staff Publications
Elements

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1002_mbo3_193.pdf2.24 MBAdobe PDF

OPEN

PublishedView/Download

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.